Clinical Potential of Neuropeptide Y Receptor Ligands in the Treatment of Epilepsy

E-ISSN： 1873-4294|7|17|1660-1674

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.17, 2007-09, pp. : 1660-1674

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptide Receptor Ligands for the Treatment of Schizophrenia: Focus on Neurotensin and Tachykinins

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3807-3812

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptide Y receptor antagonists

By Ling A.L.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 4, 1999-04 ,pp. : 375-384

Informa Healthcare

Access to resources Recommend Favorite

-1 Receptor Ligands: Potential in the Treatment of Neuropsychiatric Disorders

By Hayashi T. Su T-P.

CNS Drugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 269-284

Adis International

Access to resources Recommend Favorite

Neuropeptide Y receptor antagonists in obesity

By Gehlert D.R. Hipskind P.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1827-1838

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-10 ,pp. : 896-919

Bentham Science Publishers

Access to resources Recommend Favorite